Indexed keywords
GLUCOSE;
HEMOGLOBIN A1C;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
ANTIDIABETIC AGENT;
GLUCOSE BLOOD LEVEL;
GLYCOSYLATED HEMOGLOBIN;
ADVERSE OUTCOME;
CARDIAC PATIENT;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR MORTALITY;
CORONARY ARTERY BYPASS GRAFT;
DYSGLYCEMIA;
FOLLOW UP;
GENETIC POLYMORPHISM;
HEART INFARCTION;
HIGH RISK PATIENT;
HUMAN;
INCIDENCE;
INSULIN DEPENDENT DIABETES MELLITUS;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
SHORT SURVEY;
SMOKING CESSATION;
SYSTOLIC BLOOD PRESSURE;
BLOOD;
CARDIOVASCULAR DISEASES;
FEMALE;
GLUCOSE BLOOD LEVEL;
MALE;
METABOLISM;
BLOOD GLUCOSE;
CARDIOVASCULAR DISEASES;
DIABETES MELLITUS, TYPE 2;
FEMALE;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPOGLYCEMIC AGENTS;
MALE;
1
84930532577
Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes
Hayward, R. A., et al. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N. Engl. J. Med. 372, 2197-2206 (2015
(2015)
N. Engl. J. Med , vol.372
, pp. 2197-2206
Hayward, R.A.1
2
84882678945
Vasculopenia, and the chronic consequences of diabetes
Gerstein, H. C., & Werstuck, G. H. Dysglycaemia, vasculopenia, and the chronic consequences of diabetes. Lancet Diabetes Endocrinol. 1, 71-78 (2013
(2013)
Lancet Diabetes Endocrinol , vol.1
, pp. 71-78
Gerstein, H.C.1
Dysglycaemia, H.W.G.2
3
84920538565
Association between 7 years of intensive treatment of type 1 diabetes and long-Term mortality
Orchard, T. J., et al. Association between 7 years of intensive treatment of type 1 diabetes and long-Term mortality. JAMA. 313, 45-53 (2015
(2015)
JAMA , vol.313
, pp. 45-53
Orchard, T.J.1
4
31844443695
The environment and disease: Association or causation? Proc
Bradford-Hill, A. The environment and disease: association or causation? Proc. R. Soc. Med. 58, 295-300 (1965
(1965)
R. Soc. Med , vol.58
, pp. 295-300
Bradford-Hill, A.1
5
84898602820
Changes in diabetes-related complications in the United States 1990 -2010
Gregg, E. W., et al. Changes in diabetes-related complications in the United States, 1990-2010. N. Engl. J. Med. 370, 1514-1523 (2014
(2014)
N. Engl. J. Med , vol.370
, pp. 1514-1523
Gregg, E.W.1
6
84901590227
Cardiovascular mortality all-cause mortality and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the da qing diabetes prevention study: A 23-year follow-up study
Li, G., et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol. 2, 474-480 (2014
(2014)
Lancet Diabetes Endocrinol , vol.2
, pp. 474-480
Li, G.1
7
84939566145
Mendelian randomization analysis supports the causal role of dysglycaemia and diabetes in the risk of coronary artery disease
Ross, S., et al. Mendelian randomization analysis supports the causal role of dysglycaemia and diabetes in the risk of coronary artery disease. Eur. Heart J. 36, 1454-1462 (2015
(2015)
Eur. Heart J. , vol.36
, pp. 1454-1462
Ross, S.1
8
20044376702
The pathobiology of diabetic complications: A unifying mechanism
Brownlee, M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 54, 1615-1625 (2005
(2005)
Diabetes , vol.54
, pp. 1615-1625
Brownlee, M.1
9
70349881450
Intensive glucose control and macrovascular outcomes in type 2 diabetes
Turnbull, F. M., et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologica. 52, 2288-2298 (2009
(2009)
Diabetologica , vol.52
, pp. 2288-2298
Turnbull, F.M.1
10
84907862963
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes
Zoungas, S., et al. Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N. Engl. J. Med. 371, 1392-1406 (2014
(2014)
N. Engl. J. Med , vol.371
, pp. 1392-1406
Zoungas, S.1
